|
ZNF740 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.931400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.134020E-01 |
| Normal-vs-Stage2 |
4.275000E-01 |
| Normal-vs-Stage3 |
9.736400E-01 |
| Normal-vs-Stage4 |
6.020800E-01 |
| Stage1-vs-Stage2 |
6.646400E-01 |
| Stage1-vs-Stage3 |
3.522200E-01 |
| Stage1-vs-Stage4 |
8.959000E-01 |
| Stage2-vs-Stage3 |
6.227600E-01 |
| Stage2-vs-Stage4 |
9.136400E-01 |
| Stage3-vs-Stage4 |
6.838400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.027800E-01 |
| Normal-vs-AfricanAmerican |
9.294400E-01 |
| Normal-vs-Asian |
3.596200E-01 |
| Caucasian-vs-AfricanAmerican |
5.684000E-01 |
| Caucasian-vs-Asian |
4.452200E-01 |
| AfricanAmerican-vs-Asian |
2.916000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.001800E-01 |
| Normal-vs-Female |
7.384800E-01 |
| Male-vs-Female |
2.137800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.306000E-01 |
| Normal-vs-Extreme_Weight |
5.247700E-02 |
| Normal-vs-Obese |
7.287800E-01 |
| Normal-vs-Extreme_Obese |
9.620100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.001800E-01 |
| Normal_Weight-vs-Obese |
2.481200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.543400E-01 |
| Extreme_Weight-vs-Obese |
4.480300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.697000E-01 |
| Obese-vs-Extreme_Obese |
2.082400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.496360E-01 |
| Normal-vs-Age(41-60Yrs) |
4.552200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.457900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.488800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.408600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.491600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.953900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.818600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.293790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.322800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.863400E-01 |
| Normal-VS-Type2 PRCC |
3.523100E-03 |
| Normal-VS-KIRP CIMP |
8.263400E-01 |
| Normal-VS-Unclassified PRCC |
3.348000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.143720E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.427000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.167200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.019600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.140800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.120200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.615400E-03 |
| Normal-vs-N1 |
3.163000E-01 |
| Normal-vs-N2 |
8.873600E-01 |
| N0-vs-N1 |
1.391940E-02 |
| N0-vs-N2 |
2.699800E-01 |
| N1-vs-N2 |
7.251600E-01 |
|
|
